CAPSIDA BIOTHERAPEUTICS - Trademark Details
Status: 654 - Report Completed Suspension Check - Case Still Suspended
Image for trademark with serial number 90046614
Serial Number
90046614
Word Mark
CAPSIDA BIOTHERAPEUTICS
Status
654 - Report Completed Suspension Check - Case Still Suspended
Status Date
2021-12-01
Filing Date
2020-07-10
Mark Drawing
4000 - Standard character mark Typeset
Attorney Name
Law Office Assigned Location Code
L50
Employee Name
LAPTER, ALAIN J
Statements
Disclaimer with Predetermined Text
"BIOTHERAPEUTICS"
Goods and Services
Chemical and biochemical products for use in gene delivery technology, namely, nucleic acids, including coding and non-coding deoxyribonucleic acids, ribonucleic acids, plasmids, vectors, promotors, enhancers and other regulatory sequences; Chemical and biochemical products for use in gene delivery technology namely, nucleic acids, including coding and non-coding deoxyribonucleic acids, ribonucleic acids, plasmids, vectors, promotors, enhancers and other regulatory sequences for development of therapeutics and the treatment of autoimmune, cancer, cardiovascular, central nervous system, diabetic, dermatological, endocrine, fungal, gastrointestinal, hematologic, hepatological, immunological, infectious, inflammatory, liver, menopausal, metabolic, musculoskeletal, neurological, ophthalmologic, orthopedic, pain, peripheral nervous system, psychiatric, respiratory, renal, urogenital, urological, and viral diseases and disorders
Goods and Services
Pharmaceutical preparations for use in gene therapy; pharmaceutical preparations for use in gene delivery technology for use in the treatment of autoimmune, cancer, cardiovascular, central nervous system, diabetic, dermatological, endocrine, fungal, gastrointestinal, hematologic, hepatological, immunological, infectious, inflammatory, liver, menopausal, metabolic, musculoskeletal, neurological, ophthalmologic, orthopedic, pain, peripheral nervous system, psychiatric, respiratory, renal, urogenital, urological, and viral diseases and disorders; pharmaceutical preparations for use in the treatment of gene therapy treatable diseases for use in the treatment of autoimmune, cancer, cardiovascular, central nervous system, diabetic, dermatological, endocrine, fungal, gastrointestinal, hematologic, hepatological, immunological, infectious, inflammatory, liver, menopausal, metabolic, musculoskeletal, neurological, ophthalmologic, orthopedic, pain, peripheral nervous system, psychiatric, respiratory, renal, urogenital, urological, and viral diseases and disorders; gene therapy and prophylaxis products, namely, gene transfer, regulation, modulation and delivery pharmaceutical preparations for the treatment of genetic diseases and disorders; pharmaceutical preparations for the treatment of disorders of the central nervous system; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations that facilitate administration of other pharmaceutical preparations into the brain for enhanced treatment of disorders of the central nervous system and cancer, in the nature of drug delivery agents consisting of viral capsids that facilitate the delivery of the preparations; pre-filled syringes and vials containing pharmaceutical preparations for the treatment of autoimmune, cancer, cardiovascular, central nervous system, diabetic, dermatological, endocrine, fungal, gastrointestinal, hematologic, hepatological, immunological, infectious, inflammatory, liver, menopausal, metabolic, musculoskeletal, neurological, ophthalmologic, orthopedic, pain, peripheral nervous system, psychiatric, respiratory, renal, urogenital, urological, and viral diseases and disorders and complications associated therewith
Goods and Services
Biomanufacturing, namely, manufacturing of pharmaceuticals using biological organisms in the manufacturing process to order and/or specification of others; providing technical information in the field of pharmaceutical manufacturing; custom manufacture of pharmaceuticals; manufacture of nano scale material to the order and specification of others for use in the manufacture of other goods; manufacturing of pharmaceutical preparations for use in gene therapy to the order and specification of others; manufacturing of pharmaceutical preparations for use in gene delivery technology to the order and specification of others; manufacturing of pharmaceutical preparations for use in the treatment of gene therapy treatable diseases to the order and specification of others; manufacturing of pharmaceutical preparations for the treatment of disorders of the central nervous system to the order and specification of others; manufacturing of pharmaceutical preparations for the treatment of cancer to the order and specification of others; manufacture of pharmaceutical preparations that facilitate administration of other pharmaceutical preparations into the brain for enhanced treatment of disorders of the central nervous system and cancer to the order and specification of others; custom manufacturing of biochemical reagents, namely, synthesis for others of clinical medical reagents for use in gene therapy
Goods and Services
Pharmaceutical research and development in the field of gene therapy; consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; custom design and development of biochemical reagents, namely for use in the synthesis for others of clinical medical reagents for use in gene therapy; development of pharmaceutical preparations for use in gene therapy and gene delivery technology; development of products being genetic therapies; scientific research in the field of genetic engineering, biotechnology research services, and research and development of new products in the field of gene therapeutics and research tools; research and development in the biotechnology field; scientific and medical research and development in the field of autoimmune, cancer, cardiovascular, central nervous system, diabetic, dermatological, endocrine, fungal, gastrointestinal, hematologic, hepatological, immunological, infectious, inflammatory, liver, menopausal, metabolic, musculoskeletal, neurological, ophthalmologic, orthopedic, pain, peripheral nervous system, psychiatric, respiratory, renal, urogenital, urological, and viral diseases and disorders and complications associated therewith; scientific research and product development services for others in the pharmaceutical, biotechnology, medical and agriculture fields; testing, inspection, research, or development of pharmaceutical preparations for gene therapy and gene delivery technology; biomedical research and development, scientific research and development, pharmaceutical research and development and product development services in the fields of genome editing, gene editing, genome engineering, gene modulation, genetic diseases, gene therapy, and cell therapy; product development in the fields of genetic therapies, gene delivery technologies, and effectors to regulate, modulate, and characterize disease states; conducting clinical trials for others in the field of gene therapy design and delivery; biomedical research in the field of gene therapy design and delivery; gene therapy design and product delivery development of biochemical assays; biomedical research and development, scientific research and development, pharmaceutical research and development and product development in the fields of autoimmune, cancer, cardiovascular, central nervous system, diabetic, dermatological, endocrine, fungal, gastrointestinal, hematologic, hepatological, immunological, infectious, inflammatory, liver, menopausal, metabolic, musculoskeletal, neurological, ophthalmologic, orthopedic, pain, peripheral nervous system, psychiatric, respiratory, renal, urogenital, urological, and viral diseases and disorders; medical services, namely, scientific research in the fields of genetic engineering and gene therapy services; medical services, namely, scientific research in the nature of gene therapy design and delivery services in the field of genetic diseases and disorders
Goods and Services
Medical services for the treatment of genetic diseases and disorders through use of gene therapy; medical services in the field of autoimmune, cancer, cardiovascular, central nervous system, diabetic, dermatological, endocrine, fungal, gastrointestinal, hematologic, hepatological, immunological, infectious, inflammatory, liver, menopausal, metabolic, musculoskeletal, neurological, ophthalmologic, orthopedic, pain, peripheral nervous system, psychiatric, respiratory, renal, urogenital, urological, and viral diseases and disorders; providing patient support services relating to the treatment of medical disorders, namely, providing online medical information in the field of pharmaceutical preparations for treatment of various diseases and providing medical consultancy and advisory services via a global computer network; providing health and medical information about medical disorders; information services, namely, providing medical information to patients; providing patient support services relating to cancer and cancer treatment in the nature of an internet-based database of patient medical information where patients can inquire about medical issues and procedures from other patients and can relay information about their medical experiences for support and community; providing information services, namely, providing medical care consultancy and advisory services via a global computer network in the field of autoimmune, cancer, cardiovascular, central nervous system, diabetic, dermatological, endocrine, fungal, gastrointestinal, hematologic, hepatological, immunological, infectious, inflammatory, liver, menopausal, metabolic, musculoskeletal, neurological, ophthalmologic, orthopedic, pain, peripheral nervous system, psychiatric, respiratory, renal, urogenital, urological, and viral diseases and disorders; providing medical information services relating to treatment of medical disorders, namely, providing medical information to patients and families of patients in the field of administering medication, and patient medical information where patients can inquire about medical issues and procedures from medical personnel
Pseudo Mark
CAPSIDA BIO THERAPEUTICS
Classification Information
International Class
001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes
001, 005, 006, 010, 026, 046
Class Status Code
6 - Active
Class Status Date
2020-08-06
Primary Code
001
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
005, 006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2020-08-06
Primary Code
005
International Class
040 - Treatment of materials. - Treatment of materials.
US Class Codes
100, 103, 106
Class Status Code
6 - Active
Class Status Date
2020-08-06
Primary Code
040
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2020-08-06
Primary Code
042
International Class
044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2020-08-06
Primary Code
044
Current Trademark Owners
Party Type
11 - 1st New Owner Before Publication
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Type
11 - 1st New Owner Before Publication
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Holly Pranger
Address
Please log in with your Justia account to see this address.
Madrid International Filings
Entry Number
1
Reference Number
A0103949
Original Filing Date USPTO
2021-01-06
International Registration Number
1586291
International Registration Date
2021-01-06
International Status Code
480
International Renewal Date
2031-01-06
Madrid History Events
DateCodeDescription
2021-02-09IRREGIRREGULARITY NOTICE RECEIVED FROM IB
2021-03-15IRRACRESPONSE TO IRREGULARITY REVIEWED AND ACCEPTED
2021-03-15IRSNTIRREGULARITY RESPONSE SENT TO IB
2021-01-06NEWAPNEW APPLICATION FOR IR RECEIVED
2021-01-13MCERTMANUALLY CERTIFIED
2021-01-13APPSTIR CERTIFIED AND SENT TO IB
2021-03-10IRRCVIRREGULARITY RESPONSE RECEIVED FROM APPLICANT
2021-04-15CREATAPPLICATION FOR IR REGISTERED BY IB
Trademark Events
Event DateEvent Description
2020-07-14NEW APPLICATION ENTERED IN TRAM
2020-08-06NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2020-10-21ASSIGNED TO EXAMINER
2020-10-24NON-FINAL ACTION WRITTEN
2020-10-24NON-FINAL ACTION E-MAILED
2020-10-24NOTIFICATION OF NON-FINAL ACTION E-MAILED
2020-11-04AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
2020-12-04NON-FINAL ACTION WRITTEN
2020-12-04NON-FINAL ACTION E-MAILED
2020-12-04NOTIFICATION OF NON-FINAL ACTION E-MAILED
2021-05-27TEAS RESPONSE TO OFFICE ACTION RECEIVED
2021-05-27CORRESPONDENCE RECEIVED IN LAW OFFICE
2021-05-28TEAS/EMAIL CORRESPONDENCE ENTERED
2021-06-01EXAMINERS AMENDMENT -WRITTEN
2021-06-01EXAMINERS AMENDMENT E-MAILED
2021-06-01NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
2021-06-01EXAMINER'S AMENDMENT ENTERED
2021-06-01SUSPENSION LETTER WRITTEN
2021-06-01LETTER OF SUSPENSION E-MAILED
2021-06-01NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
2021-12-01REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED